(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

Pfizer's stock dropped 4.3 percent while Moderna's fell 3.1 percent and Novavax saw a 2.8 percent dip in its stock Friday ...

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...

Big pharma stocks needed a shot in the arm after Donald Trump chose vaccine skeptic Robert F. Kennedy Jr. as health secretary ...

Pfizer stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and ...

Elon Musk is starting to seriously annoy some in Donald Trump’s inner circle.

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...

Remember when everyone was excited the stock market spiked after Trump’s election win? Well, turns out it was very ...

Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest ...

The standout company among those yet to report is Nvidia Corp. (NVDA), which is scheduled to announce quarterly results on Wednesday.

The news prompted a sell-off across the industry. In the US, shares in Pfizer and Moderna sank more than 5% in early trading, ...